Becker's Healthcare June 24, 2025
Alexandra Murphy

A small study found that a stem cell-derived treatment helped people with Type 1 diabetes produce their own insulin and, in most cases, enabled patients to discontinue use of external insulin altogether.

The research, published June 20 in The New England Journal of Medicine, consisted of a phase 1-2 clinical trial testing zimislecel, an allogeneic stem cell-derived islet-cell therapy in 14 patients with Type 1 diabetes....

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Clinical Trials, Pharma / Biotech, Provider, Trends
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article